September 9, 2010

Close to 400 drugs and vaccines are in development for fighting infectious diseases, according to...

September 9, 2010

This week’s decision by the U.S. Second Circuit Court of Appeals could make political efforts...

September 8, 2010

NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...

September 8, 2010

Hi-Tech Pharmacal had $40.4 million in sales during its fiscal first quarter ended July 31,...

September 7, 2010

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

September 7, 2010

The generics division of Pfizer will sell an authorized generic version of a drug used...

September 7, 2010

Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...

September 7, 2010

The Food and Drug Administration has approved a generic oral contraceptive made by Watson Pharmaceuticals,...

September 6, 2010

Biotech drugs for treating Alzheimer’s disease will more than triple the size of the market...

September 6, 2010

The generics subsidiary of Pfizer is launching a new business focused on authorized generics....

September 6, 2010

Drug maker Somaxon Pharmaceuticals has made its treatment for insomnia available by prescription, the company...

September 6, 2010

GlaxoSmithKline Consumer Healthcare on Tuesday named Stacy Wallace to the newly created role of VP...

September 6, 2010

Generic drug maker Watson Pharmaceuticals has applied for Food and Drug Administration approval for a...

September 2, 2010

Pfizer is pulling out of a development deal for a potential brain cancer drug, saying...

September 1, 2010

The Food and Drug Administration has approved a generic drug made by Actavis for treating...

September 1, 2010

Teva Pharmaceuticals has launched a generic treatment for epileptic seizures....

August 31, 2010

A specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes...

August 31, 2010

A generic drug maker has received regulatory approval for its version of an attention deficit...

August 30, 2010

The Food and Drug Administration has pushed back its review date for a drug made...

August 30, 2010

After Sanofi-Aventis sent Genzyme a second proposal letter to acquire the drug maker on Monday,...

August 30, 2010

The U.S. drug market will present opportunities as well as uncertainties over the next decade,...

August 30, 2010

A generic drug maker has filed an abbreviated new drug application for its version of...

August 29, 2010

The Food and Drug Administration has posted a new list of drugs from its Adverse...

August 29, 2010

Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing,...